|
 |
|
|||||||
|
|||||||||
Diabetes 52:442-447, 2003
© 2003 by the American Diabetes Association, Inc.
Inflammation-Sensitive Plasma Proteins, Diabetes, and Mortality and Incidence of Myocardial Infarction and Stroke
A Population-Based Study
1 Department of Community Medicine, Malmö University Hospital, Malmö, Sweden
2 Department of Internal Medicine, Malmö University Hospital, Malmö, Sweden
3 Department of Vascular Diseases, Malmö University Hospital, Malmö, Sweden
This study explores the relationship of inflammation-sensitive plasma proteins (ISPs) with the prevalence of diabetes and the interrelationships between ISPs and diabetes in the prediction of death and incidence of myocardial infarction and stroke. Plasma levels of fibrinogen, 
1-antitrypsin, haptoglobin, ceruloplasmin, and orosomucoid were assessed in 6,050 men, aged 28–61 years. All-cause and cardiovascular mortality and incidence of myocardial infarction and stroke were monitored over 18.7 ± 3.7 years. Prevalence of diabetes (n = 321) was significantly associated with ISP levels among overweight and obese men but not among men with BMI <25 kg/m2. The association was similar for insulin resistance according to homeostasis model assessment. High ISP levels (two or more ISPs in the top quartile) increased the cardiovascular risk among diabetic men. The risk factor-adjusted relative risks for cardiovascular mortality, myocardial infarction, and stroke were 2.8 (CI 1.8–4.5), 2.2 (1.5–3.2), and 2.5 (1.4–4.6), respectively, for diabetic men with high ISP levels (reference: nondiabetic men with low ISP levels). The corresponding risks for diabetic men with low ISP levels were 1.8 (1.1–3.0), 1.3 (0.8–2.1), and 1.2 (0.6–2.5), respectively. In conclusion, in this population-based cohort, diabetes was associated with increased ISP levels among overweight and obese men but not among men with normal weight. High ISP levels increased the cardiovascular risk similarly in diabetic as compared with nondiabetic men.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  W T. Cade Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting Physical Therapy, November 1, 2008; 88(11): 1322 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kim, A. T. Tolhurst, L. Y. Qin, X.-Y. Chen, M. Febbraio, and S. Cho CD36/Fatty Acid Translocase, An Inflammatory Mediator, Is Involved in Hyperlipidemia-Induced Exacerbation in Ischemic Brain Injury J. Neurosci., April 30, 2008; 28(18): 4661 - 4670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Air and B. M. Kissela Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms Diabetes Care, December 1, 2007; 30(12): 3131 - 3140. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Blanner, R. A. Barve, and C. W. Bolten Mineralocorticoid Receptors and Vascular Inflammation: New Answers, New Questions Endocrinology, April 1, 2007; 148(4): 1498 - 1501. [Full Text] [PDF]
|
|
|
|
|
|
G. Fejes-Toth and A. Naray-Fejes-Toth Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling? Endocrinology, April 1, 2007; 148(4): 1502 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghavami, M. Hashemi, F. J. de Serres, S. N. Bajestani, H. Mehrabifar, and A. Leonardi Trypsin Inhibitory Capacity in Vernal Keratoconjunctivitis Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. W. Asmann, C. S. Stump, K. R. Short, J. M. Coenen-Schimke, Z. Guo, M. L. Bigelow, and K. S. Nair Skeletal Muscle Mitochondrial Functions, Mitochondrial DNA Copy Numbers, and Gene Transcript Profiles in Type 2 Diabetic and Nondiabetic Subjects at Equal Levels of Low or High Insulin and Euglycemia Diabetes, December 1, 2006; 55(12): 3309 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B Sorensen, A. Raben, S. Stender, and A. Astrup Effect of sucrose on inflammatory markers in overweight humans Am. J. Clinical Nutrition, August 1, 2005; 82(2): 421 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Karelis, M. Faraj, J.-P. Bastard, D. H. St-Pierre, M. Brochu, D. Prud'homme, and R. Rabasa-Lhoret The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4145 - 4150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Nilsson, M. Roost, G. Engstrom, B. Hedblad, and G. Berglund Incidence of Diabetes in Middle-Aged Men Is Related to Sleep Disturbances Diabetes Care, October 1, 2004; 27(10): 2464 - 2469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mustafa, T. Vukovich, T. Prikoszovich, C. Winzer, B. Schneider, H. Esterbauer, O. Wagner, and A. Kautzky-Willer Haptoglobin Phenotype and Gestational Diabetes Diabetes Care, September 1, 2004; 27(9): 2103 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, B. Hedblad, L. Stavenow, S. Jonsson, P. Lind, L. Janzon, and F. Lindgarde Incidence of Obesity-Associated Cardiovascular Disease Is Related to Inflammation-Sensitive Plasma Proteins: A Population-Based Cohort Study Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1498 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, B. Hedblad, L. Stavenow, P. Tyden, P. Lind, L. Janzon, and F. Lindgarde Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins: A Population-Based Prospective Cohort Study Circulation, July 6, 2004; 110(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Winzer, O. Wagner, A. Festa, B. Schneider, M. Roden, D. Bancher-Todesca, G. Pacini, T. Funahashi, and A. Kautzky-Willer Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus Diabetes Care, July 1, 2004; 27(7): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G F Ferraccioli and E Gremese Autoantibodies and thrombophilia in RA: TNF{alpha} and TNF{alpha} blockers Ann Rheum Dis, June 1, 2004; 63(6): 613 - 615. [Full Text]
|
|
|
|
|
|
P. Lind, G. Engstrom, L. Stavenow, L. Janzon, F. Lindgarde, and B. Hedblad Risk of Myocardial Infarction and Stroke in Smokers Is Related to Plasma Levels of Inflammation-Sensitive Proteins Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, G. Borner, B. Lindblad, L. Janzon, and F. Lindgarde Incidence of Fatal or Repaired Abdominal Aortic Aneurysm in Relation to Inflammation-Sensitive Plasma Proteins Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 337 - 341. [Abstract] [Full Text]
|
|
|
|
|
|
G. Engstrom, L. Stavenow, B. Hedblad, P. Lind, P. Tyden, L. Janzon, and F. Lindgarde Inflammation-Sensitive Plasma Proteins and Incidence of Myocardial Infarction in Men With Low Cardiovascular Risk Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2247 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, B. Hedblad, L. Stavenow, P. Lind, L. Janzon, and F. Lindgarde Inflammation-Sensitive Plasma Proteins Are Associated With Future Weight Gain Diabetes, August 1, 2003; 52(8): 2097 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |